|
" Chronic Renal Disease Causes, Complications, and Treatment. "
Cummings, Nancy B.; Klahr, S.
Document Type
|
:
|
BL
|
Record Number
|
:
|
727353
|
Doc. No
|
:
|
b547085
|
Main Entry
|
:
|
Cummings, Nancy B.; Klahr, S.
|
Title & Author
|
:
|
Chronic Renal Disease Causes, Complications, and Treatment.\ Cummings, Nancy B.; Klahr, S.
|
Publication Statement
|
:
|
Springer Verlag, 2012
|
ISBN
|
:
|
1468448269
|
|
:
|
: 9781468448269
|
Contents
|
:
|
I. Studies of Pathogenesis of Renal Disease: Research Trends in Glomerular Diseases.- 1 A Personal Perspective on the State of the Art in Research in Glomerulonephritis.- 2 Biosynthesis and Immunochemical Localization of Glomerular Components.- 3 The Role of Fixed (Native) and Planted Antigens in Glomerular Disease.- 4 Deposition of Circulating Immune Complexes in Glomeruli.- Cystic Diseases of the Kidney.- 5 Renal Cystic Disease as the Target of Research.- 6 Morphology of Human Renal Cystic Disease.- 7 Morphology of Polycystic Kidney Disease in Man and Experimental Models.- 8 Ordered and Disordered Growth of Renal Cells.- 9 Movements of Salts and Water into Cysts in Polycystic Kidney Disease.- 10 Movement of Organic Molecules into Cysts.- 11 Kinetics of Cyst Development in Cystic Renal Disease.- 12 Early Polycystic Kidney Disease.- II. Recent Advances on Some Complications of Chronic Renal Failure: Renal Osteodystrophy, Vitamin D Analogues, Parathormone.- 13 An Overview of Recent Advances in Mineral Metabolism.- 14 The Pathology of the Uremic Bone Lesion.- 15 Vitamin D Metabolism in Chronic Renal Disease.- 16 Metabolism of Parathyroid Hormone and Interpretation of Radioimmunoassays for PTH.- 17 Collagen Metabolism in Uremia.- Neurologic Complications of Renal Failure.- 18 Neurologic Complications of Renal Failure: The State of the Art.- 19 Dialysis Encephalopathy: Questions and Answers.- 20 Uremic Neuropathy.- Cardiovascular Complications of Renal Failure.- 21 Cardiovascular Complications in End-Stage Renal Disease Patients.- 22 Renal Function, Sodium, Volume, and Arterial Pressure Relationships.- 23 Abnormal Carbohydrate and Lipoprotein Metabolism in Uremia: Possible Relationship to Atherogenesis.- 24 The Role of Blood Pressure Regulation in Uremia.- 25 The Role of Manipulating Lipids in Uremia.- 26 Coronary Artery Disease in Diabetic Patients with End-Stage Renal Disease.- 27 Indicators for Cardiovascular Catastrophe in Diabetic Patients with Renal Failure.- III. Unique Problems of the Child with Renal Failure.- 28 The Child with Renal Failure: An Overview.- 29 Prevention of Renal Damage by Early Recognition of Urinary Tract Infections in Childhood.- 30 Nutritional Requirements for Growth in Children with Renal Insufficiency.- 31 Protein Utilization in Chronic Renal Insufficiency in Children.- 32 Renal Osteodystrophy in Children.- 33 Renal Transplantation in Children Aged 1-5 Years: Review of the University of Minnesota Experience.- 34 Experience with End-Stage Renal Disease Treatment of Young Children: A Brief Note.- 35 The European Experience with Treatment of End-Stage Renal Disease in Young Children.- 36 Prognosis of Renal Disease in Infancy.- IV. Selected Aspects of Therapy: Drugs and Renal Failure and Acute Problems during Hemodialysis.- 37 Drug-Induced Nephrotoxicity.- 38 Antibiotic Management of Urinary Tract Infection in the Chronic Renal Failure Patient.- 39 Contrast Media Acute Renal Failure.- 40 Effect of Renal Disease on Pharmacokinetics and Bioavailability.- 41 Pathogenesis of Aminoglycoside Nephrotoxicity.- 42 Acute Problems during Hemodialysis.- Control of Treatment Morbidity and Uremic Toxicity with Hemodialysis and Hemofiltration Therapy.- 43 The Role of Net Na and H2OFlux in the Morbidity of Hemodialysis and Hemofiltration.- 44 The Role of Small-Molecule Removal in the Control of Treatment Morbidity with Hemodialysis and Hemofiltration.- 45 The Role of Membrane Biocompatibility on the Clinical Effects of Hemodialysis Therapy.- 46 Comparative Physiology of Acetate and Bicarbonate Alkalinization.- Transplantation and Immunosuppression.- 47 The State of the Art.- 48 Use of Total Lymphoid Irradiation in Organ Transplantation.- 49 Total Lymphoid Irradiation for Immunosuppression: Review of Animal Experiments and Results of a Clinical Trial in Renal Allograft Recipients.- 50 Cyclosporin A as an Immunosuppressive Agent in Transplantation.- 51 The Pretreatment Principle in Renal Transplantation as Illustrated by Thoracic Duct Drainage.- 52 Thoracic Duct Drainage: Clinical Experience.- 53 Current Status of Induction of Specific Unresponsiveness to Organ Allografts.- 54 Immunogenetics of HLA.- Nutritional Therapy in Chronic Renal Failure.- 55 Some Questions of a Clinical Nephrologist Concerning Nutritional Therapy and Patients with Chronic Renal Failure.- 56 The Loss of Renal Enzymes: A Risk Factor for Nutritional and Metabolic Disorders.- 57 Can Low-Protein Diet Retard the Progression of Chronic Renal Failure?.- 58 Evaluation of Amino Acid Requirements in Uremia by Determination of Intracellular Free-Amino-Acid Concentrations in Muscle.- 59 Nutritional Management of Chronic Renal Failure for Two Purposes: Postponing Onset and Reducing Frequency of Dialysis.- 60 A Progressive Encephalopathy in Children with Renal Failure in Infancy.- Contributors.
|
LC Classification
|
:
|
RC918.R4C866 2012
|
Added Entry
|
:
|
Cummings, Nancy B.; Klahr, S.
|
| |